Characteristic | Number tested | Univariable OR HAV IgG | 95% CI | P value* | Multivariable OR HAV IgG | 95% CI | P value |
Total | 2577 | ||||||
Age group | |||||||
18–25 | 525 | Ref | <0.001 | Ref | <0.001 | ||
26–35 | 979 | 1.55 | 1.24 to 1.94 | 1.5 | 1.18 to 1.86 | ||
36–45 | 600 | 3.09 | 2.35 to 4.07 | 2.91 | 2.17 to 3.90 | ||
46 and over | 473 | 4.09 | 2.98 to 5.62 | 3.4 | 2.44 to 4.75 | ||
HIV status | |||||||
Negative | 2228 | Ref | <0.001 | 0.170 | |||
Positive | 349 | 3.06 | 2.37 to 2.85 | 1.82 | 1.25 to 2.64 | ||
History of STI in past year | |||||||
No | 1889 | Ref | <0.001 | Ref | <0.001 | ||
Yes | 688 | 1.71 | 1.37 to 2.12 | 1.58 | 1.25 to 2.00 | ||
Country of birth | |||||||
UK | 1363 | Ref | 0.418 | Not included | |||
Non-UK | 1123 | 1 | 0.84 to 1.21 | ||||
Unknown | 91 | 1.41 | 0.83 to 2.40 | ||||
Region of birth | |||||||
UK | 1363 | Ref | <0.001 | Ref | <0.001 | ||
Africa | 77 | 6.35 | 2.31 to 17.51 | 4.73 | 1.68 to 13.31 | ||
Americas | 230 | 1.08 | 0.78 to 1.50 | 0.64 | 0.45 to 0.91 | ||
Eastern Mediterranean | 71 | 1.71 | 0.91 to 3.22 | 1.41 | 0.72 to 2.73 | ||
Europe | 565 | 0.73 | 0.59 to 0.90 | 0.56 | 0.44 to 0.71 | ||
South-East Asia | 47 | 1.29 | 0.63 to 2.62 | 0.9 | 0.43 to 1.91 | ||
Western Pacific | 132 | 1.65 | 1.04 to 2.63 | 1.44 | 0.89 to 2.35 | ||
Unknown | 92 | 1.43 | 0.84 to 2.43 | 1.26 | 0.72 to 2.20 |
*Global p values representing the overall impact of the variable on the model.
HAV, hepatitis A virus; STI, sexually transmitted infection.